title: Tenofovir/probenecid combination in HIV/HBV-coinfected patients: how to escape Fanconi syndrome recurrence?
authors.forename: Hassane
authors.initials: H
authors.lastname: Izzedine
authors.forename: Vincent
authors.initials: V
authors.lastname: Thibault
authors.forename: Marc Antoine
authors.initials: MA
authors.lastname: Valantin
authors.forename: Gilles
authors.initials: G
authors.lastname: Peytavin
authors.forename: Luminita
authors.initials: L
authors.lastname: Schneider
authors.forename: Yves
authors.initials: Y
authors.lastname: Benhamou
mesh_terms: D000225:Adenine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005198:Fanconi Syndrome / Q000517:prevention & control*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D015497:HIV-1; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D063065:Organophosphonates / Q000008:administration & dosage* / Q000009:adverse effects; D011339:Probenecid / Q000008:administration & dosage* / Q000009:adverse effects; D055502:Secondary Prevention; D000068698:Tenofovir
chemical_list: D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine; D011339:Probenecid